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Background
Cephalosporin is one of the most commonly used
beta-lactam antibiotics globally, and also a major offending
agent of drug hypersensitivity along with penicillin. Cepha-
losporin skin test has been widely used in most hospitals
in Korea. However, the validity of this test for prediction
of immediate hypersensitivity has still not been well
studied. Therefore, we conducted this study to determine
the predictive validity of cephalosporin skin test prior to
administration.
Methods
We prospectively conducted intradermal skin test with
selected 1st, 2nd, and 3rd generation cephalosporins: cefta-
zol, cefotetan or cefamandol, ceftriaxone or cefotaxime or
flomoxef, respectively. After skin test, one of the tested
cephalosporins was intravenously administered for preo-
perative prevention of infection under careful observation,
regardless of the skin test results.
Results
We recruited 1,125 patients who needed the use of preo-
perative cephalosporins. Eighty five patients (7.5%) showed
positive skin test to at least one cephalosporin. However,
none of these patients showed immediate hypersensitivity
reactions. Two patients who showed generalized urticaria
and itching sense had negative skin test. The test showed
sensitivity of 0%, specificity of 92.4%, negative predictive
value of 99.8%, and positive predictive value 0%.
Conclusions
Routine skin test of cephalosporin prior to its administra-
tion is not valid for predicting immediate hypersensitivity
with low sensitivity and positive predictive value. This
study is currently ongoing for enrollment of larger study
group.
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